Will the competition between Levemir·Victoza and Lantus·Lyxumia get severe?

As the beneficiary standard for diabetes has been changed since the 1^st, basal insulins have been reevaluated. It seems that prescriptions of insulins will increase due to the changed beneficiary standard and recognition of joint benefits with DDP-4 inhibitors.

So far, even though a medical provider tries to prescribe insulins to patients administering DDP-4 inhibitors, it was not easy to do i...